The Weight-Loss Business, Which Long Pushed Calorie Counting and Willpower, Is Grappling With the Popularity of New Drugs

From a Wall Street Journal story by Andrea Petersen, Rolfe Winkler, and Sara Ashley O’Brien headlined “The $76 Billion Diet Industry Asks: What to Do About Ozempic?”:

Annick Lenoir-Peek, a lawyer from Durham, N.C., has struggled with her weight since adolescence. She has tried Atkins and keto and spent thousands of dollars over decades on weight-loss efforts and programs such as Noom, Nutrisystem and WeightWatchers.